« U.S. Marshals seize FDA-regulated food stored at rodent-infested warehouse in | Main | FDA Approvals - The FDA Needs Strong Medicine The organization is due for »

FDA begins process to remove breast cancer indication from Avastin


FDA begins process to remove breast cancer indication from Avastin label
The U.S. Food and Drug Administration announced today that the agency is recommending removing the breast cancer indication from the label for Avastin (bevacizumab) because the drug has not been shown to be safe and effective for that use.
 

©2006 FDA-News.com. All rights reserved.